Unknown

Dataset Information

Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach.


ABSTRACT: The four Janus kinase (JAK) proteins and seven signal transducer and activator of transcription (STAT) transcription factors mediate intracellular signal transduction downstream of cytokine receptors, which are implicated in the pathology of autoimmune, allergic and inflammatory diseases. Development of targeted small-molecule therapies such as JAK inhibitors, which have varied selective inhibitory profiles, has enabled a paradigm shift in the treatment of diverse disorders. JAK inhibitors suppress intracellular signalling mediated by multiple cytokines involved in the pathological processes of rheumatoid arthritis and many other immune and inflammatory diseases, and therefore have the capacity to target multiple aspects of those diseases. In addition to rheumatoid arthritis, JAK inhibitio

SUBMITTER: Tanaka Y 

PROVIDER: S-EPMC8730299 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature